Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Intermittent Claudication - Overview
Intermittent Claudication - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Intermittent Claudication - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Intermittent Claudication - Companies Involved in Therapeutics Development
G. Pohl-Boskamp GmbH & Co KG
Helixmith Co Ltd
ID Pharma Co Ltd
Novartis AG
Pluristem Therapeutics Inc
Intermittent Claudication - Drug Profiles
DVC-10101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
emiplacel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Cardiovascular, Dermatology and Neurology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LLG-783 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nitroglycerin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Intermittent Claudication - Dormant Projects
Intermittent Claudication - Discontinued Products
Intermittent Claudication - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Intermittent Claudication, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Intermittent Claudication, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Intermittent Claudication - Pipeline by G. Pohl-Boskamp GmbH & Co KG, H2 2020
Intermittent Claudication - Pipeline by Helixmith Co Ltd, H2 2020
Intermittent Claudication - Pipeline by ID Pharma Co Ltd, H2 2020
Intermittent Claudication - Pipeline by Novartis AG, H2 2020
Intermittent Claudication - Pipeline by Pluristem Therapeutics Inc, H2 2020
Intermittent Claudication - Dormant Projects, H2 2020
Intermittent Claudication - Discontinued Products, H2 2020